Framework Ventures IV L.P. 13D and 13G filings for NovaBay Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-21 8:12 pm Unchanged | 2026-01-16 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Framework Ventures IV L.P. | 11,361,216 45.000% | 0 (Unchanged) | Filing |
| 2025-10-20 9:42 pm Purchase | 2025-10-16 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Framework Ventures IV L.P. | 11,361,216 45.100% | 11,128,393 (+4779.77%) | Filing |
| 2025-10-15 8:28 pm Purchase | 2025-10-09 | 13D | NOVABAY PHARMACEUTICALS INC CO NBY | Framework Ventures IV L.P. | 232,823 16.200% | 232,823 (New Position) | Filing |